Expression Of CD25 Antigen On CD34+Cells Is An Independent Predictor Of Survival In Late Stage MDS Patients Treated With Azacitidine

被引:0
|
作者
Kotsianidis, Ioannis
Miltiades, Paraskevi
Lamprianidou, Eleftheria
Vassilakopoulos, Theodoros
Papageorgiou, Sotirios G.
Galanopoulos, Athanasios G.
Vakalopoulou, Sofia
Garypidou, Vassilia
Spanoudakis, Emmanouil
Papaioannou, Maria
Hadjiharissi, Evdoxia
Papadaki, Helen A.
Tsatalas, Costas
机构
关键词
D O I
10.1182/blood.V122.21.1508.1508
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1508
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Expression of CD25 antigen on CD34+cells is an independent predictor of outcome in late-stage MDS patients treated with azacitidine
    Miltiades, P.
    Lamprianidou, E.
    Vassilakopoulos, T. P.
    Papageorgiou, S. G.
    Galanopoulos, A. G.
    Vakalopoulou, S.
    Garypidou, V.
    Papaioannou, M.
    Hadjiharissi, E.
    Pappa, V.
    Papadaki, H. A.
    Spanoudakis, E.
    Tsatalas, K.
    Kotsianidis, I.
    BLOOD CANCER JOURNAL, 2014, 4 : e187 - e187
  • [2] Expression of CD25 antigen on CD34+ cells is an independent predictor of outcome in late-stage MDS patients treated with azacitidine
    P Miltiades
    E Lamprianidou
    T P Vassilakopoulos
    S G Papageorgiou
    A G Galanopoulos
    S Vakalopoulou
    V Garypidou
    M Papaioannou
    E Hadjiharissi
    V Pappa
    H A Papadaki
    E Spanoudakis
    K Tsatalas
    I Kotsianidis
    Blood Cancer Journal, 2014, 4 : e187 - e187
  • [3] ALTERED EXPRESSION OF THE REPAIR GENES IN CD34+CELLS MAY BE RESPONSIBLE FOR FORMATION AND ACCUMULATION OF MUTATIONS IN MDS PATIENTS
    Valka, J.
    Belickova, M.
    Vesela, J.
    Stara, E.
    Planetova, B.
    Jonasova, A.
    Cermak, J.
    LEUKEMIA RESEARCH, 2015, 39 : S85 - S85
  • [4] Altered Expression of the Repair Genes in CD34+Cells May be Responsible for Formation and Accumulation of Mutations in MDS Patients
    Valka, Jan
    Belickova, Monika
    Vesela, Jitka
    Stara, Eliska
    Pejsova, Barbora
    Jonasova, Anna
    BLOOD, 2015, 126 (23)
  • [5] Flow cytometric CD38 expression on CD34+cells as a simple diagnostic test inmyelodysplastic syndromes (MDS)
    Banas Llanos, M. H.
    Ibanez Espacio, F.
    Martin Aguilera, C.
    Arcos Carmona, M. J.
    Carnicero Gonzalez, F.
    Cabrera Silva, C.
    Martin Mateos, M. L.
    Fernandez Leiva, H. N.
    Prieto Fernandez, J.
    Bermejo, N.
    Garcia, M. J.
    Bergua Burgues, J. M.
    LEUKEMIA RESEARCH, 2013, 37 : S55 - S56
  • [6] Activated marrow CD8+T-lymphocytes influence marrow cellularity, fas antigen expression on CD34+cells and disease progression in patients with myelodysplastic syndromes (MDS).
    Symeonidis, A
    Karakantza, M
    Kouraklis, A
    Zoumbos, N
    BLOOD, 2001, 98 (11) : 276B - 276B
  • [7] Enhanced expression of CD69 and CD25 antigen on human peripheral blood mononuclear cells by prolactin
    Takizawa, K
    Kitani, S
    Takeuchi, F
    Yamamoto, K
    ENDOCRINE JOURNAL, 2005, 52 (05) : 635 - 641
  • [8] The number of CD34+cells in peripheral blood as a predictor of the CD34+yield in patients going to autologous stem cell transplantation
    Basquiera, A. L.
    Abichain, P.
    Damonte, J. C.
    Ricchi, B.
    Sturich, A. G.
    Palazzo, E. D.
    Garcia, J. J.
    JOURNAL OF CLINICAL APHERESIS, 2006, 21 (02) : 92 - 95
  • [9] CD25 molecule expression on peripheral blood CD4+ T cells in asthmatic patients
    Eljaszewicz, Andrzej
    Rusak, Malgorzata
    Jeznach, Marta
    Miklasz, Paula
    Dabrowska, Milena
    Moniuszko, Marcin
    Bodzenta-Lukaszyk, Anna
    ALERGIA ASTMA IMMUNOLOGIA, 2014, 19 (04): : 251 - 255
  • [10] Combined FISH- and SNP-array-analyses of circulating CD34+cells of MDS patients
    Ganster, C.
    Shimeshan, K.
    Salinas-Riester, G.
    Braulke, F.
    Schanz, J.
    Goetze, K.
    Bug, G.
    Majunke, P.
    Giagounidis, A. A. N.
    Mueller-Thomas, C.
    Truemper, L.
    Platzbecker, U.
    Haase, D.
    ONKOLOGIE, 2012, 35 : 18 - 18